http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2087271-C
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745 |
filingDate | 1991-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a26e806713fa78611f9c751cfe7a8c38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bc281798d76a45574c31c38059ebe2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc1b0cc70cd85eafe14bf2c2221bf342 |
publicationDate | 2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2087271-C |
titleOfInvention | Superior thrombomodulin analogs for pharmaceutical use |
abstract | The present invention relates to the use of analogs of thrombomodulin ("TM") that have the ability to enhance the throm-bin-mediated activation of protein C but which have a significantly reduced ability to inhibit the direct procoagulant activities of thrombin, such as, for example, thrombin-mediated conversion of fibrinogen t o fibrin. These analogs are useful in, for example, antithrombotic therapy. Novel proteins, nucleic acid gene sequences, pharmaceuticals and methods of inhibiting thrombotic ac-tivity are disclosed. Included are methods for increasing the circulating half life of the proteins. |
priorityDate | 1990-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1243.